Follow Indaptus Therapeutics, Inc. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
8 Stories, 7 about Indaptus Therapeutics, Inc 0 Programs 0 Registered trials 6-K Nov 16 Latest SEC filing Nov 16 Latest story
Timeline 7 Pipeline 0 Trials 0
Details
Headquarters New York, NY Incorporated Delaware Industry Pharmaceutical Preparations Formerly Intec Parent Inc. (to 2021) Also known as INDP, Intec Parent Inc. How the company describes itself Indaptus Therapeutics develops the Decoy platform, which uses attenuated, non-pathogenic Gram-negative bacteria to activate innate and adaptive immunity while reducing systemic toxicity. The company evaluates this immunotherapy platform and explores relationships among sleep, physical recovery, neurological function, and immune status. source